Lv3
240 积分 2023-11-26 加入
Teclistamab: Mechanism of action, clinical, and translational science
11天前
已完结
Teclistamab in Relapsed or Refractory Multiple Myeloma
3个月前
已完结
Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA’s adverse event reporting system: a case control pharmacovigilance study
3个月前
已完结
Data mining and safety analysis of traditional immunosuppressive drugs: a pharmacovigilance investigation based on the FAERS database
3个月前
已完结
Real-world Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS) Database for Asciminib
3个月前
已完结
Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database
3个月前
已完结
Cardiovascular toxicities associated with bispecific T-cell engager therapy
3个月前
已完结
Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
3个月前
已完结
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study
3个月前
已完结
Cardiovascular toxicities associated with bispecific T-cell engager therapy
3个月前
已完结
皖公网安备34019202002308
